Critic At Large

» opinion, disease/medicine and publishing

Most Recent

image: Cancer Clinical Trials of Tomorrow

Cancer Clinical Trials of Tomorrow

By | April 1, 2013

Advances in genomics and cancer biology will alter the design of human cancer studies.

0 Comments

image: Variety Is the Spice of Life

Variety Is the Spice of Life

By | February 1, 2013

True understanding of the complexity of biological systems demands an assortment of model systems.

2 Comments

image: Genomics-Informed Pathology

Genomics-Informed Pathology

By | January 1, 2013

Twenty-first century lab reports will include test results read by a new breed of pathologist.

1 Comment

image: Medicines for the World

Medicines for the World

By | October 1, 2012

A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.

0 Comments

image: Stress Tests

Stress Tests

By | September 1, 2012

Judiciously applied pressure could benefit the scientific system by providing an opportunity for renewal.

4 Comments

image: Bring On the Transparency Index

Bring On the Transparency Index

By | August 1, 2012

Grading journals on how well they share information with readers will help deliver accountability to an industry that often lacks it.

6 Comments

image: Predatory Publishing

Predatory Publishing

By | August 1, 2012

Overzealous open-access advocates are creating an exploitative environment, threatening the credibility of scholarly publishing.

29 Comments

image: All’s Not Fair in Science and Publishing

All’s Not Fair in Science and Publishing

By | July 1, 2012

False credit for scientific discoveries threatens the success and pace of research.

71 Comments

image: Polypharmacy

Polypharmacy

By | July 1, 2012

Dietary supplements can have serious side effects when mixed with prescription drugs, but not all herb-drug interactions are bad.

14 Comments

image: Regulations for Biosimilars

Regulations for Biosimilars

By | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

2 Comments

Advertisement
LI-COR
LI-COR

Popular Now

  1. Lost Y Chromosome Genes Found on Autosomes
  2. Next Generation: Souped-up Probiotics Pinpoint Cancer
  3. Llamas as Lab Rats
    Notebook Llamas as Lab Rats

    From diagnostics to vaccines, llama antibodies point to new directions in HIV research.

  4. Genomes Point the Way
    Daily News Genomes Point the Way

    Sequence analysis of Egyptian, Ethiopian, and non-African peoples indicates a likely route taken by modern humans migrating out of Africa.

Advertisement
The Scientist
The Scientist
Advertisement
BioTek
BioTek